Amsterdam's Leyden Labs secures 68M funding - Silicon CanalsLeyden Labs raised $70M to develop nasal spray solutions for respiratory virus protection, including leading-edge monoclonal antibodies.
What really CAN shorten a cold, according to scienceEarly intervention with specific nasal sprays can help reduce the severity and duration of cold symptoms.
Drug-free nasal spray blocks, neutralizes viruses, bacteria - Harvard GazetteA novel drug-free nasal spray could provide nearly 100% protection against respiratory infections if validated in human studies.
Harvard researchers might have found a way to prevent COVID, the flu-and maybe even the common coldA new nasal spray developed by Harvard researchers shows nearly 100% effectiveness in preventing respiratory infections in preclinical mice studies.
Drug-free nasal spray blocks, neutralizes viruses, bacteria - Harvard GazetteA novel drug-free nasal spray could provide nearly 100% protection against respiratory infections if validated in human studies.
Harvard researchers might have found a way to prevent COVID, the flu-and maybe even the common coldA new nasal spray developed by Harvard researchers shows nearly 100% effectiveness in preventing respiratory infections in preclinical mice studies.
EpiPen gets a new competitor: FDA approves anaphylaxis nasal sprayNasal spray with epinephrine approved by FDA for severe allergic reactions
A needle-less alternative to EpiPen has FDA approval. Will doctors prescribe it?The newly approved nasal spray Neffy offers a potential alternative to EpiPens, but concerns remain regarding its efficacy in treating life-threatening allergic reactions.
EpiPen gets a new competitor: FDA approves anaphylaxis nasal sprayNasal spray with epinephrine approved by FDA for severe allergic reactions
A needle-less alternative to EpiPen has FDA approval. Will doctors prescribe it?The newly approved nasal spray Neffy offers a potential alternative to EpiPens, but concerns remain regarding its efficacy in treating life-threatening allergic reactions.